Michael W. Yerkey
Beaumont Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael W. Yerkey.
Journal of the American College of Cardiology | 2003
Steven J. Kernis; Kishore J Harjai; Gregg W. Stone; Lorelei Grines; Judith Boura; Michael W. Yerkey; William W. O’Neill; Cindy L. Grines
OBJECTIVES We sought to identify the incidence, predictors, and clinical consequences of one-month reinfarction (RE-MI) in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). BACKGROUND One-month reinfarction after AMI significantly increases long-term mortality; however, little is known about the incidence and predictors of RE-MI in patients undergoing primary angioplasty. METHODS We analyzed data from 3,646 patients who underwent primary PCI in the Primary Angioplasty in Acute Myocardial Infarction (PAMI) studies. We studied the incidence, correlates, and clinical outcomes of 30-day RE-MI. RESULTS Reinfarction within one month of index hospitalization occurred in 77 (2.1%) of patients. In multivariate analysis, admission Killip class >1 (odds ratio [OR] 2.02, 95% confidence interval [CI] 1.09 to 3.76), left ventricular ejection fraction <50% (OR 2.49, 95% CI 1.30 to 4.74), final coronary stenosis >30% (OR 2.57, 95% CI 1.28 to 5.15), and presence of coronary dissection (OR 2.40, 95% CI 1.36 to 4.24) and thrombus (OR 2.36, 95% CI 1.23 to 4.53) on the final angiogram were independent correlates of RE-MI. One-month reinfarction was independently associated with death (OR 7.14, 95% CI 3.28 to 15.5) and ischemic target vessel revascularization (I-TVR) (OR 15.0, 95% CI 8.68 to 26.0) at six months. CONCLUSIONS We conclude that, although early RE-MI is uncommon in patients treated by primary PCI, it is a significant independent predictor of death and I-TVR at six months. Admission Killip class >1 and left ventricular systolic dysfunction were associated with higher incidence of RE-MI. Our results suggest that optimal revascularization during primary PCI may decrease RE-MI rates.
American Journal of Cardiology | 2010
Neelima Penugonda; Scott S. Billecke; Michael W. Yerkey; Murray Rebner; Pamela A. Marcovitz
Breast arterial calcium (BAC) has been suggested as a marker and predictor of cardiovascular risk and coronary artery disease (CAD). However, an association between BAC and these cardiovascular end points has not been fully elucidated in patients undergoing cardiac catheterization. Consecutive patients undergoing mammography and cardiac catheterization within a 36-month period were retrospectively evaluated through chart review. Cardiac catheterization films and mammograms from 94 patients were independently reviewed for the presence of CAD and BAC, respectively. Cardiovascular risk factors, history of revascularization, and history of myocardial infarction were compared between women with and without BAC. BAC was more prevalent in older women (mean age 69 + or - 10 vs 63 + or - 11 years, p = 0.02). Aside from an inverse correlation with smoking, there was no difference in the presence of CAD or cardiovascular risk factors between patients with and without BAC. Patients with BAC had a lesser history of acute myocardial infarction (21% vs 41%, p <0.05) and were less likely to undergo revascularization (23% vs 43%, p <0.05). In conclusion, BAC was not positively associated with cardiovascular risk factors, documented CAD, or acute cardiovascular events, suggesting that the presence of BAC as determined by mammography is not a useful predictor of CAD in intermediate- to high-risk patients.
Catheterization and Cardiovascular Interventions | 2003
Steven J. Kernis; James A. Goldstein; Michael W. Yerkey; Robert N. Levin; William W. O'Neill
We report a novel palliative treatment to improve refractory cardiogenic shock due to right ventricular ischemia. We performed percutaneous atrial septostomy to create an atrial septal defect, which resulted in immediate right ventricular decompression and increased left ventricular filling associated with prompt and dramatic hemodynamic and clinical improvement. Cathet Cardiovasc Intervent 2003;59:44–48.
American Journal of Cardiology | 2004
Beth A Bartholomew; Kishore J Harjai; Srinivas Dukkipati; Judith Boura; Michael W. Yerkey; Susan Glazier; Cindy L. Grines; William W. O'Neill
American Journal of Cardiology | 2005
Pamela A. Marcovitz; Hillary H. Tran; Barry A. Franklin; William W. O’Neill; Michael W. Yerkey; Judith Boura; Michael Kleerekoper; Christine Z. Dickinson
Journal of the American College of Cardiology | 2004
Srinivas Dukkipati; William W. O'Neill; Kishore J Harjai; William P Sanders; Datinder Deo; Judith Boura; Beth A Bartholomew; Michael W. Yerkey; H.Mehrdad Sadeghi; Joel K. Kahn
Journal of the American College of Cardiology | 2004
Michael W. Yerkey; Murray Rebner; Christine Z. Dickinson; Judith Boura; Pamela A. Marcovitz
Archive | 2010
Michael W. Yerkey; William W. O'Neill; Cindy L. Grines; Steven J. Kernis; Kishore J. Harjai; Gregg W. Stone; Lorelei Grines; Ana Judith
Journal of the American College of Cardiology | 2003
Srinivas R. Dukkipati; Datinder Deo; H. Mehrdad Sadeghi; Michael W. Yerkey; Judith Boura; Beth A. Bartholomew; Kishore J. Harjai; William W. O'Neill; Joel K. Kahn; William Beaumont
Journal of the American College of Cardiology | 2003
Beth A. Bartholomew; Kishore J. Harjai; Judith Boura; Srinivas R. Dukkipati; Michael W. Yerkey; Lorelei Grines; Bruce R. Brodie; David A. Cox; Gregg W. Stone; William W. O'Neill; Cindy L. Grines